Fed. Circ. Clarifies Law For Functional Antibody Claims
On Oct. 5, the Federal Circuit issued a decision in Amgen Inc. v. Sanofi (No. 2017-1480), a closely watched case involving functional antibody claims, claims that define antibodies not by their...To view the full article, register now.
Already a subscriber? Click here to view full article